Literature DB >> 14382544

Dapsone in dermatitis herpetiformis.

J K MORGAN, C W MARSDEN, J G COBURN, J M MUNGAVIN.   

Abstract

Entities:  

Keywords:  DERMATITIS HERPETIFORMIS/therapy; SULFONES/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 14382544     DOI: 10.1016/s0140-6736(55)90692-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  DAPSONE-INDUCED HAEMOLYSIS.

Authors:  C D PENGELLY
Journal:  Br Med J       Date:  1963-09-14

2.  Agranulocytosis Following Dapsone Therapy.

Authors:  W B McKenna; A C Chalmers
Journal:  Br Med J       Date:  1958-02-08

3.  The Treatment of Dermatitis Herpetiformis with Diaminodiphenyl Sulphone.

Authors:  R Jackson
Journal:  Can Med Assoc J       Date:  1955-11-01       Impact factor: 8.262

Review 4.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

5.  The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.

Authors:  R L Degowin; R B Eppes; R D Powell; P E Carson
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

Review 6.  Dapsone in the management of autoimmune bullous diseases.

Authors:  Evan W Piette; Victoria P Werth
Journal:  Immunol Allergy Clin North Am       Date:  2012-04-18       Impact factor: 3.479

7.  N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.

Authors:  H Uehleke; S Tabarelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.